Over the past 16 months, the Trump ad­min­is­tra­tion’s phar­ma tar­iffs have loomed large over the in­dus­try. While the first wave of these levies was sched­uled...

The US has fol­lowed through on its $600 mil­lion fund­ing com­mit­ment to Gavi, a glob­al vac­cine con­sor­tium, af­ter the funds were held in lim­bo for...

HH­S' Health Re­sources and Ser­vices Ad­min­is­tra­tion un­veiled de­tails of a re­vised 340B re­bate pi­lot, which will let some drug man­u­fac­tur­ers de­ny re­bates for a small...

Capri­cor Ther­a­peu­tics failed to win the back­ing of an FDA ad­vi­so­ry pan­el for de­ramio­cel, a ther­a­py in­tend­ed to slow the rate of de­cline in car­diac...

A ma­jor­i­ty of FDA ad­vi­sors backed Replimune’s ad­vanced melanoma treat­ment, vot­ing in fa­vor of the prod­uct’s ef­fi­ca­cy and the da­ta pro­duced in its study, mark­ing...

The Trump ad­min­is­tra­tion’s nom­i­nee to be the next CDC di­rec­tor has won the sup­port of a key Sen­ate com­mit­tee, send­ing her nom­i­na­tion to the full...

Neil Vasan, act­ing chair of the FDA's On­co­log­ic Drugs Ad­vi­so­ry Com­mit­tee, told End­points Newsthat he's stepped down from the com­mit­tee. He's par­tic­i­pat­ed in 22...